Menopause Clinical Trials
AstraOne runs menopause and perimenopause clinical trials for pharma, device, wearable, and digital therapeutics teams — with deep experience in vasomotor, sleep, and mood endpoints.
What we deliver
Vasomotor symptom (VMS) trials
Hot flash frequency and severity capture with validated diaries and wearable sensors.
Perimenopause studies
Cycle-aware protocols with hormonal, symptom, and PRO endpoints.
Menopause sleep endpoints
PSG, actigraphy, and PRO-based sleep evaluation in menopausal populations.
HRT and non-hormonal therapy trials
Hormonal and non-hormonal therapy studies with safety-forward designs.
Menopause DTx and digital health
Digital therapeutics and coaching intervention studies for menopause symptoms.
Wearable and app validation
Clinical validation of menopause tracking apps and connected symptom monitors.
Built for regulatory-grade evidence
- Menopause specialty site network and recruitment channels
- VMS, sleep, mood, and cognitive endpoint expertise
- Integrated wearable and ePRO capture
- Regulatory strategy for menopause pharma and DTx
Frequently asked questions
How do you recruit menopause clinical trial participants?
AstraOne uses a specialty women's health site network combined with targeted digital outreach and pre-screened patient communities to enroll perimenopausal and postmenopausal participants for clinical trials.
Ready to scope your study?
Talk to our clinical operations team about protocol design, recruitment, and execution.